Virtual Special Issue: Epigenetics 2022.
作者信息
Aldrich Courtney C, Calderón Félix, Conway Stuart J, He Chuan, Hooker Jacob M, Huryn Donna M, Lindsley Craig W, Liotta Dennis C, Müller Christa E
出版信息
ACS Pharmacol Transl Sci. 2022 Sep 9;5(10):829-834. doi: 10.1021/acsptsci.2c00169. eCollection 2022 Oct 14.
Abstract
摘要
相似文献
1
Virtual Special Issue: Epigenetics 2022.
ACS Pharmacol Transl Sci. 2022 Sep 9;5(10):829-834. doi: 10.1021/acsptsci.2c00169. eCollection 2022 Oct 14.
2
Virtual Special Issue: Epigenetics 2022.
ACS Infect Dis. 2022 Oct 14;8(10):1975-1980. doi: 10.1021/acsinfecdis.2c00434. Epub 2022 Sep 8.
3
Virtual Special Issue: Epigenetics 2022.
ACS Chem Biol. 2022 Oct 21;17(10):2673-2678. doi: 10.1021/acschembio.2c00661.
4
Virtual Special Issue: Epigenetics 2022.
J Med Chem. 2022 Sep 22;65(18):11894-11899. doi: 10.1021/acs.jmedchem.2c01386. Epub 2022 Sep 8.
5
Virtual Special Issue: Epigenetics 2022.
ACS Med Chem Lett. 2022 Oct 13;13(10):1524-1529. doi: 10.1021/acsmedchemlett.2c00393.
6
Monoliths: special issue in a new package.
J Sep Sci. 2013 Aug;36(16):i-ii. doi: 10.1002/jssc.201370153.
7
2019 environment, epigenetics and reproduction.
Environ Epigenet. 2019 Dec 23;5(4):dvz025. doi: 10.1093/eep/dvz025. eCollection 2019 Oct.
8
Environment, epigenetics and reproduction.
Environ Epigenet. 2017 Oct 10;3(3):dvx018. doi: 10.1093/eep/dvx018. eCollection 2017 Jul.
9
In this issue of Epigenetics: special focus on environmental epigenetics.
Epigenetics. 2011 Jul;6(7):789-90. doi: 10.4161/epi.6.7.16674.
10
Epigenetics 2.0: Special Issue on Epigenetics-Call for Papers.
J Med Chem. 2020 Nov 12;63(21):12129-12130. doi: 10.1021/acs.jmedchem.0c01748. Epub 2020 Oct 22.
本文引用的文献
1
Structure-Activity Relationship and Evaluation of - and -PCPA-Derived Inhibitors of LSD1 and LSD2.
ACS Med Chem Lett. 2022 Aug 18;13(9):1485-1492. doi: 10.1021/acsmedchemlett.2c00294. eCollection 2022 Sep 8.
2
Tricyclic Carboxamide Derivatives as PRMT5 Inhibitors for Treating Cancer.
ACS Med Chem Lett. 2022 Jul 12;13(8):1204-1205. doi: 10.1021/acsmedchemlett.2c00292. eCollection 2022 Aug 11.
3
Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation.
ACS Med Chem Lett. 2022 Jul 7;13(8):1363-1369. doi: 10.1021/acsmedchemlett.2c00198. eCollection 2022 Aug 11.
4
Nanoacetylated -(4-Hydroxyphenyl) Retinamide Modulates Histone Acetylation-Methylation Epigenetic Disparity to Restrict Epithelial-Mesenchymal Transition in Neuroblastoma.
ACS Med Chem Lett. 2022 Jun 27;13(7):1109-1117. doi: 10.1021/acsmedchemlett.2c00135. eCollection 2022 Jul 14.
5
Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies.
ACS Med Chem Lett. 2022 Jun 7;13(7):1137-1143. doi: 10.1021/acsmedchemlett.2c00167. eCollection 2022 Jul 14.
6
Effects of Structurally Different HDAC Inhibitors against , , and .
ACS Infect Dis. 2022 Jul 8;8(7):1356-1366. doi: 10.1021/acsinfecdis.2c00232. Epub 2022 Jun 22.
7
Design and Synthesis of Tranylcypromine-Derived LSD1 Inhibitors with Improved hERG and Microsomal Stability Profiles.
ACS Med Chem Lett. 2022 Apr 29;13(5):848-854. doi: 10.1021/acsmedchemlett.2c00120. eCollection 2022 May 12.
8
Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity.
ACS Med Chem Lett. 2022 Mar 16;13(5):779-785. doi: 10.1021/acsmedchemlett.1c00702. eCollection 2022 May 12.
9
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach.
J Med Chem. 2022 Sep 8;65(17):11574-11606. doi: 10.1021/acs.jmedchem.2c00252. Epub 2022 Apr 28.
10
Essential Bromodomain BDF2 as a Drug Target against Chagas Disease.
ACS Infect Dis. 2022 May 13;8(5):1062-1074. doi: 10.1021/acsinfecdis.2c00057. Epub 2022 Apr 28.
Zotero 插件